rs28930069
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 | common in clinvar |
(C;G) | 6.6 | Malignant Hyperthermia susceptibility |
(G;G) | 5 | Hypokalemic periodic paralysis risk |
Reference | GRCh38 38.1/141 |
Chromosome | 1 |
Position | 201053539 |
Gene | CACNA1S |
is a | snp |
is | mentioned by |
dbSNP | rs28930069 |
dbSNP (classic) | rs28930069 |
ClinGen | rs28930069 |
ebi | rs28930069 |
HLI | rs28930069 |
Exac | rs28930069 |
Gnomad | rs28930069 |
Varsome | rs28930069 |
LitVar | rs28930069 |
Map | rs28930069 |
PheGenI | rs28930069 |
Biobank | rs28930069 |
1000 genomes | rs28930069 |
hgdp | rs28930069 |
ensembl | rs28930069 |
geneview | rs28930069 |
scholar | rs28930069 |
rs28930069 | |
pharmgkb | rs28930069 |
gwascentral | rs28930069 |
openSNP | rs28930069 |
23andMe | rs28930069 |
SNPshot | rs28930069 |
SNPdbe | rs28930069 |
MSV3d | rs28930069 |
GWAS Ctlg | rs28930069 |
Max Magnitude | 6.6 |
rs28930069, also known as R1239G or Arg1239Gly, is a SNP in the CACNA1S gene on chromosome 1.
The rs28930069(G) allele has been reported in a family study to be the basis for their hypokalemic periodic paralysis, type 1.[PMID 8004673]
This variant meets the criteria published in 2013 by the ACMG regarding incidental findings in exome or genome sequencing, as a variant that they do recommend informing a patient about.[PMID 23788249]
ClinVar | |
---|---|
Risk | Rs28930069(G;G) |
Alt | Rs28930069(G;G) |
Reference | Rs28930069(C;C) |
Significance | Pathogenic |
Disease | Hypokalemic periodic paralysis 1 |
Variation | info |
Gene | CACNA1S |
CLNDBN | Hypokalemic periodic paralysis 1 |
Reversed | 1 |
HGVS | NC_000001.10:g.201022667G>C |
CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
CLNACC | RCV000019191.28, |
[PMID 3037387] Primary structure of the receptor for calcium channel blockers from skeletal muscle.
[PMID 8004673] Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
[PMID 11353725] Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.